Deutsche Bank analyst Imron Zafar last night initiated coverage of Intuitive Surgical with a Buy rating and $630 price target. Intuitive is the dominant global leader in robotic surgery and one of the premier medtech growth stories, Zafar tells investors in a research note. Further, the analyst believes a “still-underpenetrated” worldwide surgery market leaves “substantial runway for continued robust sales growth.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.